2. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ranks second among the best cheap biotech stocks to buy now. BioMarin specializes in developing treatments for rare genetic diseases and life-threatening medical conditions, making it one of the more established players in the rare disease biotechnology space.
The company reported quarterly revenue of $875 million, surpassing analyst expectations. Despite a modest earnings miss due to accounting adjustments related to Roctavian, several analysts maintained bullish ratings on the stock.
Bernstein raised its price target to $94 while maintaining an Outperform rating, highlighting strong product demand for enzyme therapies and continued adoption of Voxzogo.
BioMarin’s pipeline includes several promising therapies targeting rare diseases, including Valoctocogene roxaparvovec and BMN 307, both of which could support future growth.
Click next to see the following stock...
